Isbn: 9781108838665 - alzheimer's disease drug development: research and development ecosystem (8 Ergebnisse)

Paperback. Zustand: Fine.

hardcover. Zustand: Good. Cover and edges may have some wear.

hardcover. Zustand: Very Good. Cover and edges may have some wear. Mild to Moderate creasing / bending to covers and pages.

hardcover. Zustand: Like New. A firm and square hardback with sharp corners and strong joints just showing a few very minor rubs. Hence a non-text page has a small 'damaged' stamp. Despite such this book is actually in nearly new condition and appears unread. Thus the contents are crisp, fresh and tight. Also, no pen-marks and not from a library so no such stamps or labels. Now offered for sale at a very sensible price.…

Zustand: New. In English.

Zustand: New.

Hardcover. Zustand: Brand New. 1st edition. 554 pages. 10.00x7.25x1.25 inches. In Stock.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clinical trials, and funding and financing models. Also discussed is the critical role of advocacy fundraising for drug development. With the approval of aducanumab, the function of the ecosystem has become apparent. This is a definitive overview of how the ecosystem works in transferring an AD drug from its discovery in the laboratory through clinical trial testing to regulatory review and eventual marketing. …